1-206960921-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001170631.2(FCAMR):āc.955A>Gā(p.Met319Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000451 in 1,552,256 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001170631.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FCAMR | NM_001170631.2 | c.955A>G | p.Met319Val | missense_variant | 6/8 | ENST00000324852.9 | NP_001164102.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FCAMR | ENST00000324852.9 | c.955A>G | p.Met319Val | missense_variant | 6/8 | 2 | NM_001170631.2 | ENSP00000316491.4 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152242Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000126 AC: 2AN: 158622Hom.: 0 AF XY: 0.0000120 AC XY: 1AN XY: 83592
GnomAD4 exome AF: 0.00000357 AC: 5AN: 1400014Hom.: 0 Cov.: 31 AF XY: 0.00000290 AC XY: 2AN XY: 690486
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152242Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74382
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 15, 2024 | The c.955A>G (p.M319V) alteration is located in exon 6 (coding exon 6) of the FCAMR gene. This alteration results from a A to G substitution at nucleotide position 955, causing the methionine (M) at amino acid position 319 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at